Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study
Journal of Drugs in Dermatology · 2024
DOI: 10.36849/jdd.8249 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Zaim Haq und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Metformin, Skin Neoplasms, Basal Cell Carcinoma, Propensity Score. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Haq, Z., Mirza, F. N., Abdi, P., Diaz, M. J., & Libby, T. J. (2024). Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8249
Vancouver
Haq Z, Mirza FN, Abdi P, Diaz MJ, Libby TJ. Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.8249
BibTeX
@article{Haq2024,
author = {Haq, Zaim and Mirza, Fatima N and Abdi, Parsa and Diaz, Michael J and Libby, Tiffany J},
title = {Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study},
journal = {Journal of Drugs in Dermatology},
year = {2024},
doi = {10.36849/jdd.8249}
}
EUVIMED